Skip to main content

Mahoney David L's Form 4 filing

Corcept Therapeutics IncCORT · filed Aug 20, 2026

Accession no.
0001193125-26-359255
Filed
Aug 20, 2026, 4:30 PM ET
Trade date
Aug 18, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions. Open-market sales total $12.3M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mahoney David LCIK 0001224091Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2026Common StockSSaleDisposed−4,984$117.47F2−$585,478.451,232,161Indirect
Aug 18, 2026Common StockSSaleDisposed−91,167$118.24F3−$10,779,367.281,140,994Indirect
Aug 18, 2026Common StockSSaleDisposed−7,055$118.88F4−$838,710.391,133,939Indirect
Aug 18, 2026Common StockSSaleDisposed−400$119.64F5−$47,855.241,133,539Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

Remarks

The power of attorney under which this form was signed is on file with the Commission.

Read the full filing on SEC EDGAR (opens in a new tab)